Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

  • There is currently no data for CARR

Acquisition

23 Jun 2010 07:00

RNS Number : 0769O
Carr's Milling Industries PLC
23 June 2010
 



 

 

IMMEDIATE RELEASE

23 June 2010

 

 

 

CARR'S MILLING INDUSTRIES PLC

("Carr's" or "the Company")

 

Carr's (CRM.L), the agriculture, food and engineering group, is delighted to announce that it has acquired Scotmin Nutrition Limited ("Scotmin") and A C Burn Limited ("borthwickburn") from Buccleuch Country Limited for a total consideration of £5.62 million payable in cash out of the Company's existing banking facilities.

 

Scotmin is a manufacturer and distributor of animal feed supplements, based in Ayr, Scotland, where it employs 41 people. It has been trading for over 31 years and is a major supplier to the Scottish market. The products manufactured and supplied by Scotmin include mineral supplements, protein balances, molassed feed mineral blocks, forage additives and colostrum products.

 

For the year ended 31 October 2009, Scotmin generated revenues of £8.0 million and operating profit of £0.55 million. On completion, Scotmin's net assets and gross assets are expected to amount to £2.42 million and £4.31 million respectively.

 

The acquisition of Scotmin, for £4.82 million, will create one of the UK's leading feed and mineral block manufacturer and supplier which will be well placed to achieve growth in revenues and profits.

 

Scotmin has established a strong reputation for its supplement range which will complement the existing range of feed block products currently manufactured and marketed by Caltech. The enlarged business will offer an outstanding range of high quality, proven products to livestock farmers seeking to enhance the efficiency of forage utilisation. For Scotmin, this will result in opportunities to sell its range of supplements to existing Caltech feed block customers and distributors both in the UK and Europe.

 

In addition to expanding Scotmin's trading area outside its Scottish homebase, integration will result in significant buying and other efficiencies which are expected to boost profitability in the first year following acquisition.

 

The management team at Scotmin will remain with the business and will oversee the development of the many cross selling opportunities the Company expects to exist for the enlarged business.

 

borthwickburn, which is being acquired for £0.8 million, is engaged in the sale of animal feed and proprietary animal health products and trades from three locations - Jedburgh, Selkirk and Berwick. The acquisition extends the number of retail branches operating in northern England and Scotland from 15 to 18.

 

For the year ended 31 October 2009, borthwickburn generated revenues of £3.2 million and operating profit of £28,000. On completion, borthwickburn's net assets and gross assets are expected to amount to £0.53 million and £1.17 million respectively.

 

Following integration, both Scotmin and borthwickburn are expected to enhance the Company's earnings for the financial year ending 3 September 2011.

 

The Board expects to issue Carr's Interim Management Statement for the third quarter of the current financial year by mid-July.

 

END

 

Enquiries:

 

Carr's Milling Industries plc

Chris Holmes (Chief Executive)

Ron Wood (Finance Director)

01228-554 600

Bankside Consultants Limited

Simon Bloomfield

Rose Oddy

 

020-7367 8861

020-7367 8863

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFTMTTMBBTTTM
Date   Source Headline
12th Dec 20247:00 amRNSFull Year Results
10th Dec 20245:52 pmRNSHolding(s) in Company
6th Dec 20246:24 pmRNSDirectorate Change
12th Nov 20245:09 pmRNSDirectorate Change
18th Oct 202411:54 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSTrading Update
6th Aug 20242:58 pmRNSTotal Voting Rights
1st Aug 20241:42 pmRNSDirectorate Change
1st Aug 202410:24 amRNSResults of AGM 2024 - Update Statement
12th Jul 202411:03 amRNSHolding(s) in Company
1st Jul 202412:32 pmRNSTotal Voting Rights
1st Jul 20249:25 amRNSBlock listing six monthly return
1st Jul 20249:24 amRNSBlock listing six monthly return
26th Jun 20241:47 pmRNSHolding(s) in Company
10th Jun 20247:00 amRNSChange of Registered Office
7th Jun 20244:22 pmRNSDirector/PDMR Shareholding
14th May 202410:00 amRNSDirector/PDMR Shareholding
8th May 20242:24 pmRNSTotal Voting Rights
24th Apr 202410:31 amRNSReplacement: Strategic Update and Interim Results
18th Apr 20247:00 amRNSStrategic Update and Interim Results
15th Apr 202411:45 amRNSAppointment of Joint Corporate Broker
9th Apr 20247:00 amRNSTotal Voting Rights
7th Mar 202412:57 pmRNSTotal Voting Rights
22nd Feb 202412:40 pmRNSTotal Voting Rights
21st Feb 20242:58 pmRNSResult of Annual General Meeting 2024
31st Jan 20241:36 pmRNSBlocklisting Application
29th Jan 20249:48 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
16th Jan 202410:15 amRNSHolding(s) in Company
15th Jan 20243:13 pmRNSHolding(s) in Company
10th Jan 20245:29 pmRNSNotice of AGM 2024 and 2023 Annual Report
9th Jan 202412:43 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
27th Dec 20237:22 amRNSPublication of Annual Report and Accounts 2023
21st Dec 20237:00 amRNSFull Year Results
13th Dec 20231:03 pmRNSNotice of Results
13th Nov 20237:00 amRNSLeadership Changes and Notice of Results
1st Nov 20233:22 pmRNSOutcome of Shareholder Engagement
16th Oct 20232:13 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSTrading Update
6th Oct 20234:09 pmRNSNon-Executive Director Succession
2nd Oct 20239:44 amRNSHolding(s) in Company
31st Aug 20239:52 amRNSTotal Voting Rights
16th Aug 20234:24 pmRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSCEO succession
4th Aug 20237:00 amRNSTrading Update
18th Jul 20239:07 amRNSHolding(s) in Company
7th Jul 20239:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.